« Study: Alcohol tied to 75,000 deaths a year in U.S. | Main | UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapi »

Costliest New Drugs Escape Patient, Insurer Revolt

By Kim Dixon and Ransdell Pierson

CHICAGO/NEW YORK (Reuters) - When it comes to the price tag for the newest biotechology drugs for cancer and other hard-to-treat diseases, the sky is likely to remain the limit, insurers, drugmakers and industry watchers say.

Neither HMOs nor the government-sponsored Medicare program is seriously challenging unprecedented costs for the new drugs, which include rheumatoid arthritis and multiple sclerosis treatments.

Article from: Reuters.com

Posted by Cindy Gruwell on September 24, 2004 12:24 PM |

The views and opinions expressed in this page are strictly those of the page author. The contents of this page have not been reviewed or approved by the University of Minnesota.